Best practice guidelines on genetic diagnostics of Facioscapulohumeral muscular dystrophy: Workshop 9th June 2010, LUMC, Leiden, The Netherlands

Neuromuscular Disorders

Volumn 22, Issue 5, 2012, Pages 463-470

  Lemmers, Richard J L F ^a   O'Shea, Suzanne ^b   Padberg, George W ^c   Lunt, Peter W ^d   van der Maarel, Silvère M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ST MICHAEL'S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; DNA;

ARTICLE; CHROMOSOME 10Q; CHROMOSOME 4Q; CONSENSUS DEVELOPMENT; CPG ISLAND; D4Z4 GENE; DIFFERENTIAL DIAGNOSIS; DNA MARKER; DNA METHYLATION; EXTENSOR MUSCLE; FACE PAIN; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FLUORESCENCE IN SITU HYBRIDIZATION; FOOT; FSHD GENE; FSHD1 GENE; FSHD2 GENE; GENE; GENE LOCUS; GENE REARRANGEMENT; GENETIC ANALYSIS; GENETIC SCREENING; GENETIC VARIABILITY; GENETICS; HIGH THROUGHPUT SCREENING; HUMAN; LEUKOCYTE; MOLECULAR COMBING; MOLECULAR DIAGNOSIS; MUSCLE WEAKNESS; NETHERLANDS; PELVIC GIRDLE; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREIMPLANTATION GENETIC DIAGNOSIS; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RANDOM AMPLIFIED MICROSATELLITE; SCAPULA; SENSITIVITY AND SPECIFICITY; SHOULDER DISEASE; SOUTHERN BLOTTING; SSLP MARKER; SYMPTOMATOLOGY; WORKSHOP;

GENETIC MARKERS; GENETIC TESTING; HUMANS; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; NETHERLANDS;

EID: 84859651987     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2011.09.004     Document Type: Article

References (27)

1. Tawil R., van der Maarel S., Padberg G.W., van Engelen B.G. 171st ENMC international workshop: standards of care and management of facioscapulohumeral muscular dystrophy. Neuromuscul Disord 2010, 20:471-475.
2. Padberg G.W. Facioscapulohumeral muscular dystrophy: a clinician's experience. Facioscapulohumeral muscular dystrophy. Clinical medicine and molecular cell biology 2004, 41-54. Garland Science/BIOS Scientific Publishers, Oxon, UK. M. Upadhyaya, D.N. Cooper (Eds.).
3. van der Maarel S.M., Tawil R., Tapscott S.J. Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence. Trends Mol Med 2011, 17:252-258.
4. Lemmers R.J., van der Vliet P.J., van der Gaag K.J., et al. Worldwide population analysis of the 4q and 10q subtelomeres identifies only four discrete interchromosomal sequence transfers in human evolution. Am J Hum Genet 2010, 86:364-377.
5. Bakker E., Wijmenga C., Vossen R.H., et al. The FSHD-linked locus D4F104S1 (p13E-11) on 4q35 has a homologue on 10qter. Muscle Nerve 1995, 2:39-44.
6. Lemmers R.J., de Kievit P., Sandkuijl L., et al. Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere. Nat Genet 2002, 32:235-236.
7. Lemmers R.J., van der Vliet P.J., Klooster R., et al. A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 2010, 329:1650-1653.
8. Lemmers R.J., Wohlgemuth M., Frants R.R., Padberg G.W., Morava E., van der Maarel S.M. Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy. Am J Hum Genet 2004, 75:1124-1130.
9. Lemmers R.J.L.F., van der Wielen M.J.R., Bakker E., Padberg G.W., Frants R.R., van der Maarel S.M. Somatic mosaicism in FSHD often goes undetected. Ann Neurol 2004, 55:845-850.
10. Lemmers R.J., Osborn M., Haaf T., et al. D4F104S1 deletion in facioscapulohumeral muscular dystrophy: phenotype, size, and detection. Neurology 2003, 61:178-183.
11. van Overveld P.G., Lemmers R.J., Sandkuijl L.A., et al. Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat Genet 2003, 35:315-317.
12. Goto K., Nishino I., Hayashi Y.K. Rapid and accurate diagnosis of facioscapulohumeral muscular dystrophy. Neuromuscul Disord 2006, 16:256-261.
13. Nguyen K, Walrafen P, BR, Attarian S, et al. Molecular combing reveals allelic combinations in facioscapulohumeral dystrophy. Ann Neurol, in press. 2011.
14. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
15. Lemmers R.J.L.F., van der Wielen M.J.R., Bakker E., van der Maarel S.M. Molecular diagnosis of FSHD. Facioscapulohumeral muscular dystrophy. Clinical medicine and molecular cell biology 2004, 211-234. Garland Science/BIOS Scientific Publishers, Oxon, UK. M. Upadhyaya, D.N. Cooper (Eds.).
16. Kruchen B, Rueger B. The DIG System-Nonradioactive and Highly Sensitive Detection of Nucleic Acids. BIOCHEMICA 3, 2003.
17. Deidda G., Cacurri S., Piazzo N., Felicetti L. Direct detection of 4q35 rearrangements implicated in facioscapulohumeral muscular dystrophy (FSHD). J Med Genet 1996, 33:361-365.
18. Lemmers R.J.L., de Kievit P., van Geel M., et al. Complete allele information in the diagnosis of facioscapulohumeral muscular dystrophy by triple DNA analysis. Ann Neurol 2001, 50:816-819.
19. Matsumura T., Goto K., Yamanaka G., et al. Chromosome 4q;10q translocations; comparison with different ethnic populations and FSHD patients. BMC Neurol 2002, 2:7.
20. van der Maarel S.M., Deidda G., Lemmers R.J., et al. De Novo Facioscapulohumeral Muscular Dystrophy: frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between Chromosomes 4 and 10. Am J Hum Genet 2000, 66:26-35.
21. Tonini M.M., Lemmers R.J., Pavanello R.C., et al. Equal proportions of affected cells in muscle and blood of a mosaic carrier of facioscapulohumeral muscular dystrophy. Hum Genet 2006, 119:23-28.
22. Ehrlich M., Jackson K., Tsumagari K., Camano P., Lemmers R.J. Hybridization analysis of D4Z4 repeat arrays linked to FSHD. Chromosoma 2007, 116:107-116.
23. de Greef J.C., Lemmers R.J., Camano P., et al. Clinical features of facioscapulohumeral muscular dystrophy 2. Neurology 2010, 75:1548-1554.
24. Barat-Houari M., Nguyen K., Bernard R., et al. New multiplex PCR-based protocol allowing indirect diagnosis of FSHD on single cells: can PGD be offered despite high risk of recombination?. Eur J Hum Genet 2010, 18:533-538.
25. Lemmers R.J., Wohlgemuth M., van der Gaag K.J., et al. Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy. Am J Hum Genet 2007, 81:884-894.
26. Tsumagari K., Chen D., Hackman J.R., Bossler A.D., Ehrlich M. FSH dystrophy and a subtelomeric 4q haplotype: a new assay and associations with disease. J Med Genet 2010, 47:745-751.
27. Buzhov B.T., Lemmers R.J., Tournev I., et al. Genetic confirmation of facioscapulohumeral muscular dystrophy in a case with complex D4Z4 rearrangments. Hum Genet 2005, 116:262-266.